FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

34609311000001105: Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Aug 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104697501000001116 Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104697601000001117 Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Is a Dipyridamole+aspirin 200mg/25mg m/r capsule false Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has active ingredient Dipyridamole true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has active ingredient Aspirin true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has manufactured dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has specific active ingredient Dipyridamole true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has specific active ingredient Aspirin true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Is a Atransipar true Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Is a Dipyridamole 200mg modified-release / Aspirin 25mg capsules false Inferred relationship Existential restriction modifier
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Is a Dipyridamole 200mg modified-release / Aspirin 25mg capsules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) 60 capsule Has AMP True Atransipar 200mg/25mg modified-release capsules (Par Laboratories Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start